TrimRx's Blog

10 min read

AstraZeneca Obesity Pipeline: What’s Coming

AstraZeneca arrived late to the obesity drug race.

10 min read

Are Online GLP-1 Programs Safe: 2026 Honest Assessment

Introduction Online GLP-1 programs can be safe when they use state-licensed clinicians, source from registered compounding or retail pharmacies, screen patients for contraindications, and…

9 min read

AOD-9604: Can You Stack It with GLP-1 Medications?

The question comes up often in peptide forums and clinic intake calls.

11 min read

AOD-9604 What the Research Actually Says: Evidence Review

AOD-9604 has one of the most lopsided gaps in the peptide world between what marketing copy promises and what the published literature shows.

12 min read

AOD-9604 How It Works: Mechanism of Action Explained Simply

AOD-9604 is a 16-amino-acid peptide carved out of the tail end of human growth hormone. The name AOD stands for Anti-Obesity Drug.

11 min read

AOD-9604 Dosing Protocol: Cycling, Frequency & Best Practices

AOD-9604 has no FDA-approved dose because it has no FDA-approved indication.

15 min read

AOD-9604 Complete Guide: Benefits, Dosing, Side Effects & Research

AOD-9604 is a synthetic peptide built from the last 16 amino acids of the human growth hormone (hGH) molecule (residues 177-191).

9 min read

What to Do When Anthem Denies Zepbound: Step-by-Step Appeal

Anthem owns 14 Blue Cross Blue Shield licensees and processes pharmacy benefits through CarelonRx (formerly IngenioRx), Anthem’s wholly-owned PBM.

10 min read

What to Do When Anthem Denies Wegovy: Appeal Strategy

Introduction Anthem owns 14 Blue Cross Blue Shield licensees across the US: California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New…

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.